In the pipeline are three novel biologics, 10 vaccines, and two new chemical entities set to complete phase 1 clinical…
Early-stage average deal value $50 m plus, cheque size double.
Cadila’s new chemical entity (NCE) pipeline includes two new drugs being developed to treat diabetes and anaemia.
On Tuesday, Israel-based pharma company Teva announced an unsolicited offer to buy Mylan…
Face regulatory delays, mull shifting overseas
Global private equity investment firm Carlyle completely exited its investment in leading pharmaceutical company Claris Lifesciences…
With the complex generics segment growing at twice the pace of the commoditised generics, Indian drugmakers are investing in R&D…
Profitable exits for Sequoia Capital, ICICI Venture Funds, ChrysCapital
Private equity (PE) and venture capital (VC) firms have written to the finance ministry seeking clarity on certain key proposals…
Funds are consistently reporting below-average returns for past decade.
A day after Wockhardt said that the recent USFDA’s follow-up inspection was to assess the progress made in areas of…
Tepid primary markets dampen profitability
On Thursday, Foodpanda raised $110 million in fresh funding from Rocket Internet and other investors…
Foodpanda raised $110 million in a fresh round of fund raising from Rocket Internet and other investors.
In what shows rising confidence in the Indian startup ecosystem, SAIF Partners, a venture capital and growth equity…
Vishakha Mulye, managing director and CEO of ICICI Venture, India’s largest homegrown private equity (PE) firm, estimates PE investments…
Even as private equity (PE) funds seek to raise capital to increase their investment exposure to India, their limited partners…
SAIF Partners, the private equity (PE) firm that has assets of $1 billion under management in India…
